列沃多巴损害了体外感官神经元中的溶酶体功能
Oyedele J Olaoye1, Asya Esin Aksoy1, Santeri V Hyytiäinen1
1Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Biology
|November 27, 2024
概括
高剂量利沃多巴是帕金森病 (PD) 的关键治疗方法,通过影响线粒体和溶解体,损害了感官神经元功能. 这些对神经元的有害影响是独立于同类半氨酸发生的.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特征是运动症状.
- 非运动症状和外围神经病变在PD患者中越来越多地被识别出来.
- 高剂量利沃多巴,主要的PD治疗,被怀疑会诱导或恶化神经病变,可能是通过同类氨酸.
研究的目的:
- 为了研究勒沃多巴对感觉神经元的直接影响.
- 检查勒沃多巴对神经元形态,线粒体功能和溶酶体活动的影响.
- 为了确定勒沃多巴对感觉神经元的影响是否由同型半氨酸介导.
主要方法:
- 主要培养的背部根和感觉神经元细胞系被用levodopa治疗.
- 评估了细胞形态,线粒体膜潜力,以及 lysosomal 含量和酸度.
- 研究了同类半氨酸在勒沃多巴效应中的作用.
主要成果:
- 高剂量的乐伏多巴降低了感官神经元中的线粒体膜潜力.
- 在患者相关的度下,Levodopa暴露增加了β3素免疫反活性.
- 利沃多巴通过减少 lysosome 含量和酸度而损害了 lysosomal 功能,独立于 homocysteine.
结论:
- 利沃多巴虽然对帕金森病治疗至关重要,但在治疗度下对感觉神经元产生有害影响.
- 这些对神经元功能的不良影响,特别是溶酶体活性,不能归因于同类半氨酸.
- 这些发现突出了勒沃多巴诱导的PD患者神经病变的潜在机制.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:24Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K